High Cholesterol Completed Phase 3 Trials for Evolocumab (DB09303)

Also known as: High Blood Cholesterol Level / Hypercholesterolemia / Hypercholesteremia / Hypercholesterolaemia / Congenital xanthoma / Hypercholesteraemia / Elevated cholesterol

IndicationStatusPhase
DBCOND0037835 (High Cholesterol)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02304484Open-label Extension (OLE) Study to Assess Safety and Efficacy of EvolocumabTreatment
NCT01813422GLobal Assessment of Plaque reGression With a PCSK9 antibOdy as Measured by intraVascular UltrasoundTreatment
NCT01516879Durable Effect of PCSK9 Antibody CompARed wiTh placEbo StudyTreatment
NCT02634580Goal Achievement After Utilizing an Anti-PCSK9 Antibody in Statin Intolerant Subjects-4Treatment
NCT02739984Evaluation of Evolocumab (AMG 145) Efficacy in Diabetic Adults With Hypercholesterolemia/Mixed DyslipidemiaTreatment
NCT03429998Evolocumab Versus LDL Apheresis in Patients With HypercholesterolemiaTreatment
NCT02585895Trial Assessing Evolocumab(AMG145) Compared to LDL-C Apheresis in Subjects Receiving LDL-C Apheresis Prior to Study EnrollmentTreatment